Cite
COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls.
MLA
Kowdley, Kris V., et al. “COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls.” The American Journal of Gastroenterology, Aug. 2024. EBSCOhost, https://doi.org/10.14309/ajg.0000000000003029.
APA
Kowdley, K. V., Hirschfield, G. M., Coombs, C., Malecha, E. S., Bessonova, L., Li, J., Rathnayaka, N., Mells, G., Jones, D. E., Trivedi, P. J., Hansen, B. E., Smith, R., Wason, J., Hiu, S., Kareithi, D. N., Mason, A. L., Bowlus, C. L., Muller, K., Carbone, M., … Villamil, A. (2024). COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls. The American Journal of Gastroenterology. https://doi.org/10.14309/ajg.0000000000003029
Chicago
Kowdley, Kris V, Gideon M Hirschfield, Charles Coombs, Elizabeth S Malecha, Leona Bessonova, Jing Li, Nuvan Rathnayaka, et al. 2024. “COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls.” The American Journal of Gastroenterology, August. doi:10.14309/ajg.0000000000003029.